FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386105031> ?p ?o ?g. }

• W4386105031 abstract "Abstract Background Hepatitis C virus (HCV) infection is the major cause of liver cirrhosis and hepatocellular carcinoma (HCC); thus, effective and safe treatment is crucial. Aim of the Work to evaluate the serum angiopoietin-2 as non-invasive marker of fibrosis regression in patients with Hepatitis C Virus receiving DAA drugs. Patients and Methods This study was conducted on 40 chronic HCV-patients who received DAA therapy in the Hepatic Virology Unit and the gastroenterology department of Ain Shams University hospitals. All patients were subjected to the following: Full history taking with stress concerning the hepatology system, clinical evaluation, laboratory investigations, Routine investigations: Abdominal and Pelvic ultrasonography and Transient elastography (Fibroscan) to measure liver stiffness measurement (LSM) for detection the degree of liver fibrosis in the chronic HCV-patients. Results Hematological findings, biochemical liver profile and liver fibrosis indices except hemoglobin level and platelets counts were significantly improved after DAA therapy. There was a significant improvement concerning the fibrosis stage after the treatment fibrosis staging at SVR12. The liver size, the spleen size and portal vein diameter were also significant after DAA therapy. There was improvement in the Child-Pugh score after successful HCV eradication by DAAs but the difference was no statistically significant. There was a statistically significant higher mean of Ang-2 levels in higher stages of liver fibrosis stages. Overall, serum Ang-2 levels significantly decrease after DAA therapy. In F0, F1, F2 & F3 fibrosis stage; the mean Ang2 levels decrease after DAA therapy but in F4 fibrosis stage; the mean Ang2 levels did not change almost. Baseline Ang-2 and WBCs, AST, ALT, total bilirubin, INR, serum albumin, alpha-fetoprotein, serum creatinine, LSM, FIB-4 index, APRI score, liver size and portal vein diameter were significantly correlated. There were also a significant correlation between Ang-2 and all the fibrosis stages (from F0 to F4) before DAA treatment. Ang-2 levels were significantly associated with LSM based liver fibrosis stage regression after successful DAA therapy. Ang-2 levels did not correlate with hemoglobin, platelets and spleen size at baseline. Ang-2 levels did not correlate with hemoglobin, platelets, WBCs, INR, spleen size and portal vein diameter after DAA therapy. Ang-2 levels did not show significant correlation with the Child-Pugh score after DAA therapy. Conclusion Liver fibrosis stage after successful HCV eradication by DAAs. But in stage F4 (cirrhosis), mean Ang-2 remained almost unchanged after DAA therapy. Significant decrease of Serum Ang-2 could suggest its use as a predictor of liver fibrosis regression in Hepatitis C Virus-patients after Direct Acting Antiviral drugs after DAA therapy." @default.
• W4386105031 created "2023-08-24" @default.
• W4386105031 creator A5022078230 @default.
• W4386105031 creator A5081642528 @default.
• W4386105031 creator A5092682383 @default.
• W4386105031 creator A5092682384 @default.
• W4386105031 date "2023-06-01" @default.
• W4386105031 modified "2023-09-25" @default.
• W4386105031 title "Angiopoietin-2 as a Predictor of Fibrosis Regression in Hepatitis C Virus-Patients after Direct Acting Antiviral Drugs" @default.
• W4386105031 doi "https://doi.org/10.1093/qjmed/hcad069.495" @default.
• W4386105031 hasPublicationYear "2023" @default.
• W4386105031 type Work @default.
• W4386105031 citedByCount "0" @default.
• W4386105031 crossrefType "journal-article" @default.
• W4386105031 hasAuthorship W4386105031A5022078230 @default.
• W4386105031 hasAuthorship W4386105031A5081642528 @default.
• W4386105031 hasAuthorship W4386105031A5092682383 @default.
• W4386105031 hasAuthorship W4386105031A5092682384 @default.
• W4386105031 hasConcept C126322002 @default.
• W4386105031 hasConcept C203014093 @default.
• W4386105031 hasConcept C2522874641 @default.
• W4386105031 hasConcept C2776408679 @default.
• W4386105031 hasConcept C2776455275 @default.
• W4386105031 hasConcept C2777214474 @default.
• W4386105031 hasConcept C2778019345 @default.
• W4386105031 hasConcept C2780559512 @default.
• W4386105031 hasConcept C2780826214 @default.
• W4386105031 hasConcept C2993667909 @default.
• W4386105031 hasConcept C2994217296 @default.
• W4386105031 hasConcept C41260117 @default.
• W4386105031 hasConcept C71924100 @default.
• W4386105031 hasConcept C90924648 @default.
• W4386105031 hasConceptScore W4386105031C126322002 @default.
• W4386105031 hasConceptScore W4386105031C203014093 @default.
• W4386105031 hasConceptScore W4386105031C2522874641 @default.
• W4386105031 hasConceptScore W4386105031C2776408679 @default.
• W4386105031 hasConceptScore W4386105031C2776455275 @default.
• W4386105031 hasConceptScore W4386105031C2777214474 @default.
• W4386105031 hasConceptScore W4386105031C2778019345 @default.
• W4386105031 hasConceptScore W4386105031C2780559512 @default.
• W4386105031 hasConceptScore W4386105031C2780826214 @default.
• W4386105031 hasConceptScore W4386105031C2993667909 @default.
• W4386105031 hasConceptScore W4386105031C2994217296 @default.
• W4386105031 hasConceptScore W4386105031C41260117 @default.
• W4386105031 hasConceptScore W4386105031C71924100 @default.
• W4386105031 hasConceptScore W4386105031C90924648 @default.
• W4386105031 hasIssue "Supplement_1" @default.
• W4386105031 hasLocation W43861050311 @default.
• W4386105031 hasOpenAccess W4386105031 @default.
• W4386105031 hasPrimaryLocation W43861050311 @default.
• W4386105031 hasRelatedWork W1934155416 @default.
• W4386105031 hasRelatedWork W1967442145 @default.
• W4386105031 hasRelatedWork W1982541345 @default.
• W4386105031 hasRelatedWork W2008626862 @default.
• W4386105031 hasRelatedWork W2021351004 @default.
• W4386105031 hasRelatedWork W2027011970 @default.
• W4386105031 hasRelatedWork W2057741435 @default.
• W4386105031 hasRelatedWork W2577971132 @default.
• W4386105031 hasRelatedWork W2770458351 @default.
• W4386105031 hasRelatedWork W2809604588 @default.
• W4386105031 hasVolume "116" @default.
• W4386105031 isParatext "false" @default.
• W4386105031 isRetracted "false" @default.
• W4386105031 workType "article" @default.